[go: up one dir, main page]

HK1028198A - Treatment of diabetes with rosiglitazone and insulin - Google Patents

Treatment of diabetes with rosiglitazone and insulin Download PDF

Info

Publication number
HK1028198A
HK1028198A HK00106906.0A HK00106906A HK1028198A HK 1028198 A HK1028198 A HK 1028198A HK 00106906 A HK00106906 A HK 00106906A HK 1028198 A HK1028198 A HK 1028198A
Authority
HK
Hong Kong
Prior art keywords
rosiglitazone
insulin
diabetes
treatment
Prior art date
Application number
HK00106906.0A
Other languages
Chinese (zh)
Inventor
Alistair Smith Stephen
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1028198A publication Critical patent/HK1028198A/en

Links

HK00106906.0A 1997-06-18 1998-06-15 Treatment of diabetes with rosiglitazone and insulin HK1028198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712866.4 1997-06-18

Publications (1)

Publication Number Publication Date
HK1028198A true HK1028198A (en) 2001-02-09

Family

ID=

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
AU2511295A (en) Dual barrel syringe and method of use
AU3791799A (en) Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
AU1380699A (en) Composition and method for increasing insulin activity
IL133143A0 (en) Treatment of diabetes with rosiglitazone and insulin
AP9801267A0 (en) Treatment of insulin resistance
AP2000001733A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and diguanide
AU5840200A (en) Treatment of diabetes and related pathologies
AU1924795A (en) Treatment and/or prevention of type i diabetes mellitus with gamma interferon administration
AU6160594A (en) Diabetes prevention and treatment
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
IL133137A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AP2000001734A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
AU2940895A (en) Use of insulin and igf-i
AU4073299A (en) Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
AU9106491A (en) Method of preventing and treating insulin dependent diabetes mellitus
HK1028198A (en) Treatment of diabetes with rosiglitazone and insulin
AU7572696A (en) Treatment of diabetes with a glucokinase gene
AU4107797A (en) Compounds for the treatment and prevention of diabetes
AU5926998A (en) Treatment of diabetes with synthetic beta cells
AU5479798A (en) Treatment of diabetes with transcription factor gene
AU9797598A (en) Treatment of diabetic retinopathy
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
HK1025263A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor